Better Buy: GlaxoSmithKline PLC vs. Johnson & Johnson

Two big drugmakers have seen their stocks go in opposite directions over the last five years GlaxoSmithKline NYSE GSK shareholders lost more than 10 during the period while Johnson amp Johnson NYSE JNJ shareholders have enjoyed gains of over 75 Which of